Pedieos IVF Center
A number of reproductive issues can affect human reproduction and make conception and pregnancy more difficult and sometimes impossible, so the dream of having a child is not as easy as in nature.
Today, modern medical science can help overcome most of the problems and dramatically increase the chances of getting pregnant and having a child.
At PEDIEOS IVF CENTER, we offer the best in fertility and reproductive medicine, including state of the art procedures and the very latest in advanced laboratory techniques.
The Center is located in the capital of Cyprus, Nicosia. It was established in 1986 by Dr. K. M. Trokoudes M.D., F.R.C.P. (C) who had a leading role in reproductive medicine in Cyprus and Greece.
The Center is the first in Greece and Cyprus to achieve pregnancies with the following methods:
* Gamete Intra-Fallopian Transfer (GIFT) - 1987
* Zygote Intra-Fallopian Transfer (ZIFT) - 1988
* Testicular Sperm Extraction (TESA)
* Micro Epididymal Sperm Aspiration (MESA)
* Intra Cytoplasmic Semen Injection (ICSI) - 1992
* Ovum Donation - 1990
PEDIEOS IVF CENTER was the first worldwide, to have achieved pregnancy with globozoospermia (rare but severe disorder in male infertility where the spermatozoa is characterized by 100% round headed spermatozoa lacking an acrosome). (Human Reproduction, 1995, Vol.10, w. 4, pp. 880-882-Case Report)
Our recent work on the vitrification of human embryos was published in Reproductive Biomedicine Online Journal (Vitrification of biopsied embryos at cleavage, morula and blastocyst stage (2009)Reprod Biomed Online Oct;19(4):526-31).
Furthermore, our last work on the virification of human oocytes was published in Fertility and Sterility ( Comparison outcome of fresh and vitrified donor oocytes in an egg-sharing donation program (2011) Fertility and Sterility May;95(6):1996-2000)
The center was also featured in the GUINESS BOOK OF RECORDS (1992-1993) for achieving a pregnancy in the oldest mother in the world for those 2 years.
The center received a licenced certificate for the EU Cell and Tissue Directive requirements.
